• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚 2002-2015 年植入式心脏转复除颤器治疗情况。

Implantable cardioverter-defibrillator therapy in Australia, 2002-2015.

机构信息

Agnes Ginges Centre for Molecular Cardiology, Centenary Institute, Sydney, NSW

Centre for Health Research, University of Wollongong, Wollongong, NSW.

出版信息

Med J Aust. 2018 Aug 6;209(3):123-129. doi: 10.5694/mja17.01183. Epub 2018 Jul 30.

DOI:10.5694/mja17.01183
PMID:30041593
Abstract

OBJECTIVES

To quantify the number of implantable cardioverter-defibrillator (ICD) procedures in Australia by year, patient age and sex, and to estimate age group-specific population rates and the associated costs. Design, setting: Retrospective observational study; analysis of Australian National Hospital Morbidity Database hospital procedures data.

PARTICIPANTS

Patients with an ICD insertion, replacement, adjustment, or removal procedure code, July 2002 - June 2015.

MAIN OUTCOME MEASURES

Number of ICD procedures by procedure year, patient age (0-34, 35-69, 70 years or more) and sex; age group-specific population procedure rates; number of procedures associated with complications.

RESULTS

The number of ICD procedures increased from 1844 in 2002-03 to 6504 in 2014-15; more than 75% of procedures were in men. In 2014-15, the ICD insertion rate for people aged 70 years or more was 78.1 per 100 000 population, 22 per 100 000 for those aged 35-69 years, and 1.40 per 100 000 people under 35. The reported complication rate decreased from 45% in 2002-03 to 19% in 2014-15, partly because of a change in the coding of complications. The number of removals corresponded to at least 4% of the number of insertions each year. The aggregate cost of hospitalisations with an ICD procedure during 2011-14 was $445 644 566.

CONCLUSION

ICD procedures are becoming more frequent in Australia, particularly in people aged 70 or more. Patterns of care associated with ICD therapy, particularly patient- and hospital-related factors associated with adverse events, should be investigated to better understand and improve patient outcomes.

摘要

目的

按年份、患者年龄和性别量化澳大利亚植入式心脏复律除颤器 (ICD) 程序的数量,并估计特定年龄组的人群发生率和相关成本。设计、设置:回顾性观察研究;对澳大利亚国家医院发病率数据库医院程序数据进行分析。

参与者

ICD 插入、更换、调整或移除程序代码的患者,2002 年 7 月至 2015 年 6 月。

主要观察指标

每年 ICD 程序数量、患者年龄(0-34、35-69、70 岁及以上)和性别;特定年龄组人群程序发生率;与并发症相关的程序数量。

结果

2002-03 年 ICD 程序数量为 1844 例,2014-15 年增加至 6504 例;超过 75%的程序是男性。2014-15 年,70 岁及以上人群 ICD 插入率为每 10 万人 78.1 例,35-69 岁人群为每 10 万人 22 例,35 岁以下人群为每 10 万人 1.40 例。2002-03 年报告的并发症发生率为 45%,2014-15 年降至 19%,部分原因是并发症编码发生了变化。每年的移除数量至少相当于插入数量的 4%。2011-14 年与 ICD 程序相关的住院总费用为 445644566 美元。

结论

在澳大利亚,ICD 程序的应用越来越频繁,特别是在 70 岁及以上的人群中。应调查与 ICD 治疗相关的护理模式,特别是与不良事件相关的患者和医院相关因素,以更好地了解和改善患者的预后。

相似文献

1
Implantable cardioverter-defibrillator therapy in Australia, 2002-2015.澳大利亚 2002-2015 年植入式心脏转复除颤器治疗情况。
Med J Aust. 2018 Aug 6;209(3):123-129. doi: 10.5694/mja17.01183. Epub 2018 Jul 30.
2
Trends in the use of implantable cardioverter defibrillators in Australia: a 10-year nationwide study from 2000-2009.澳大利亚植入式心脏复律除颤器使用趋势:2000-2009 年全国范围内 10 年研究。
Intern Med J. 2013 Aug;43(8):888-95. doi: 10.1111/imj.12201.
3
Manufacturer change and risk of system-related complications after implantable cardioverter defibrillator replacement: physicians' survey and data from the Detect Long-term Complications After Implantable Cardioverter Defibrillator Replacement Registry.制造商变更与植入式心律转复除颤器更换后系统相关并发症风险:来自植入式心律转复除颤器更换后长期并发症检测登记研究的医生调查和数据。
J Cardiovasc Med (Hagerstown). 2017 Dec;18(12):968-975. doi: 10.2459/JCM.0000000000000572.
4
Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness evaluation.可穿戴除颤器预防感染性植入式心脏复律除颤器移除后心脏性猝死的成本效益评估。
Heart Rhythm. 2015 Jul;12(7):1565-73. doi: 10.1016/j.hrthm.2015.03.061. Epub 2015 Mar 31.
5
A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.对不同患者群体中植入式心脏复律除颤器治疗的效果和成本相关证据的综述,以及在英国背景下对这些群体的成本效益和成本效用进行建模。
Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. doi: 10.3310/hta10270.
6
Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry.可穿戴除颤器在植入式除颤器取出后对患者的保护益处:来自国家登记处的结果。
JACC Clin Electrophysiol. 2017 Mar;3(3):243-250. doi: 10.1016/j.jacep.2016.09.002. Epub 2016 Nov 23.
7
[Spanish Implantable Cardioverter-Defibrillator Registry. Fourth Official Report of the Spanish Society of Cardiology Working Group on Implantable Cardioverter-Defibrillators (2007)].[西班牙植入式心脏复律除颤器注册研究。西班牙心脏病学会植入式心脏复律除颤器工作组第四次官方报告(2007年)]
Rev Esp Cardiol. 2008 Nov;61(11):1191-203.
8
Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.瑞典植入式电子设备的使用现状:来自瑞典起搏器和植入式心脏复律除颤器注册中心的数据。
Europace. 2015 Jan;17(1):69-77. doi: 10.1093/europace/euu233. Epub 2014 Oct 21.
9
Estimating the Risks and Benefits of Implantable Cardioverter Defibrillator Generator Replacement: A Systematic Review.植入式心脏复律除颤器发生器更换的风险与获益评估:一项系统评价
Pacing Clin Electrophysiol. 2016 Jul;39(7):709-22. doi: 10.1111/pace.12850. Epub 2016 Apr 29.
10
Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry.双腔植入式心律转复除颤器的选择与 NCDR 植入式心律转复除颤器登记处纳入的患者的并发症发生率和死亡率增加有关。
J Am Coll Cardiol. 2011 Aug 30;58(10):1007-13. doi: 10.1016/j.jacc.2011.04.039.

引用本文的文献

1
Burden of mood symptoms and disorders in implantable cardioverter defibrillator patients: a systematic review and meta-analysis of 39 954 patients.植入式心脏复律除颤器患者心境症状和障碍的负担:39954 例患者的系统评价和荟萃分析。
Europace. 2023 Jun 2;25(6). doi: 10.1093/europace/euad130.
2
Arrhythmia in Cardiomyopathy: Sex and Gender Differences.心肌病中的心律失常:性别差异。
Curr Heart Fail Rep. 2021 Oct;18(5):274-283. doi: 10.1007/s11897-021-00531-0. Epub 2021 Sep 22.
3
Sex Differences in Hypertrophic Cardiomyopathy: Interaction With Genetics and Environment.
肥厚型心肌病的性别差异:与遗传和环境的相互作用。
Curr Heart Fail Rep. 2021 Oct;18(5):264-273. doi: 10.1007/s11897-021-00526-x. Epub 2021 Sep 3.
4
Primary Prevention Implantable Cardiac Defibrillators: A Townsville District Perspective.原发性预防植入式心脏除颤器:汤斯维尔地区视角
Front Cardiovasc Med. 2020 Oct 27;7:577248. doi: 10.3389/fcvm.2020.577248. eCollection 2020.
5
Changes in the Physical Function and Psychological Distress from Pre-Implant to 1, 6, and 12 Months Post-Implant in Patients Undergoing Implantable Cardioverter Defibrillator Therapy.接受植入式心脏复律除颤器治疗的患者从植入前到植入后1个月、6个月和12个月的身体功能和心理困扰变化。
J Clin Med. 2020 Jan 22;9(2):307. doi: 10.3390/jcm9020307.